糖生物學市場規模、佔有率和成長分析：按產品類型、應用、最終用戶和地區分類－2026-2033年產業預測

2024 年全球Glico市場價值為 23 億美元，預計到 2025 年將成長至 26.4 億美元，到 2033 年將成長至 80.3 億美元，在預測期（2026-2033 年）內複合年成長率為 14.9%。

全球Glico市場正經歷顯著成長，這主要得益於對個人化醫療的關注以及生物製藥研究的進步。對標靶治療的需求日益成長，凸顯了理解複雜碳水化合物結構及其在細胞和分子功能中作用的必要性。在質譜等分析技術創新的支持下，製藥和生技領域的研發投入不斷增加。產學合作進一步加速了知識累積和實際應用，尤其是在疾病診斷和治療方面。然而，聚醣的結構複雜性、熟練專家的短缺以及高昂的研發成本等挑戰可能會阻礙發展，尤其是在發展中地區，最終影響Glico在醫學領域的廣泛應用和商業化。

全球Glico市場促進因素

世界各國政府正大力投資醣質學研究，以改善健康並推動科學知識發展。例如，許多國家已啟動大規模資助舉措，旨在加強研究活動，最終增加高技能科學研究人員的數量。這些投資不僅促進了創新，也有助於提升Glico領域的研究能力。隨著各國政府將健康相關研究列為優先事項，對醣質學研究的需求不斷成長，從而對整個Glico市場的發展產生了積極影響。對資金和資源分配的日益重視，正在推動新技術和調查方法的開發，進一步拓展這一領域。

全球Glico市場面臨的限制因素

阻礙全球Glico市場擴張的主要障礙是醣質學研究設備的高成本，尤其是高效液相層析（HPLC）系統和質譜儀。這些先進儀器的價格可能高達數十萬甚至數百萬美元，令小規模研究機構和新興生技公司難以負擔。此外，糖分析所需的專用試劑成本也推高了營運成本，限制了醣質學技術的應用。因此，這些經濟障礙對該領域的創新和發展構成了重大挑戰。

全球Glico市場趨勢

全球Glico市場正經歷顯著成長，這主要得益於人們對個人化醫療日益成長的興趣，而個人化醫療則強調個人化的治療方法。這種不斷變化的市場格局凸顯了醣質學在開發基於獨特聚醣譜的標靶治療發揮的關鍵作用，這些療法能夠增強藥物對特定疾病的療效。隨著醫療保健系統擴大採用個人化治療方案，對Glico創新技術的需求預計將會擴大。此外，聚醣分析技術的進步及其在藥物研發和診斷中的應用，進一步推動了市場擴張，使醣質學成為未來治療方法和精準醫療的重要組成部分。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球糖生物學市場規模：依產品類型分類

• 酵素
  • 糖苷酶
  • 神經氨酸酶
  • 糖基轉移酶
  • 唾液酸轉移酶
  • 其他
• 裝置
  • 質譜儀
  • HPLC
  • MALDI-TOF
  • 陣列系統
• 碳水化合物
  • 單醣
  • 寡糖
  • 多醣
  • 其他碳水化合物
• 成套工具
  • 聚醣標記試劑盒
  • 聚醣純化試劑盒
  • 糖釋放試劑盒
• 試劑

全球糖生物學市場規模：按應用領域分類

• 診斷
• 藥物發現
• 腫瘤學
• 免疫學
• 其他用途

全球糖生物學市場規模：依最終用戶分類

• 製藥公司
• 生技公司
• 受託研究機構
• 其他最終用戶

全球糖生物學市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Thermo Fisher Scientific
• New England Biolabs
• Merck KGaA
• Promega Corporation
• Waters Corporation
• Takara Bio Inc
• Bio-Techne
• Agilent Technologies
• Bruker Corporation
• Danaher Corporation
• Shimadzu Corporation
• AMS Bio
• Ludger Ltd
• Z Biotech, LLC
• Chemily Glycoscience
• CD BioGlyco
• GlycoDiag
• Kode Biotech Limited
• Glyxera GmBH
• Sialix Inc.

結論與建議

Global Glycobiology Market size was valued at USD 2.3 Billion in 2024 and is poised to grow from USD 2.64 Billion in 2025 to USD 8.03 Billion by 2033, growing at a CAGR of 14.9% during the forecast period (2026-2033).

The global glycobiology market is experiencing significant growth driven by the emphasis on personalized medicine and advancements in biopharmaceutical research. The demand for targeted therapies fuels the necessity to understand complex carbohydrate structures and their roles in cellular and molecular functions. Increased investments in research and development are being seen within the pharmaceutical and biotechnology sectors, supported by innovations in analytical technologies like mass spectrometry. Collaborations between academia and industry further enhance knowledge and practical applications, particularly in disease diagnosis and therapy. However, challenges such as the structural complexity of glycans, a shortage of trained professionals, and high research costs can hinder progress, especially in developing regions, ultimately affecting the widespread adoption and commercialization of glycobiology applications in healthcare.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Glycobiology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Glycobiology Market Segments Analysis

Global Glycobiology Market is segmented by Product Type, Application, End User and region. Based on Product Type, the market is segmented into Enzymes, Instruments, Carbohydrates, Kits and Reagents. Based on Application, the market is segmented into Diagnostics, Drug Discovery, Oncology, Immunology and Other Applications. Based on End User, the market is segmented into Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Glycobiology Market

Governments worldwide are significantly investing in glycomics research to improve health outcomes and advance scientific knowledge. For instance, substantial funding initiatives have been launched in various countries to bolster research activities, ultimately aiming to increase the number of skilled scientific professionals. These investments not only foster innovation but also enhance research capabilities within the field of glycobiology. As governments prioritize health-related research, the demand for glycomics research increases, positively impacting the overall growth of the glycobiology market. This increased focus on funding and resource allocation supports the development of new technologies and methodologies, further driving the sector's expansion.

Restraints in the Global Glycobiology Market

A major obstacle hindering the expansion of the Global Glycobiology market is the high cost associated with glycomics research equipment, particularly high-performance liquid chromatography (HPLC) systems and mass spectrometers. The prices of these sophisticated instruments can reach from hundreds of thousands to millions of dollars, making them unaffordable for smaller research laboratories and emerging biotechnology firms. Additionally, the expense of specialized reagents necessary for glycan analysis further elevates operational costs, limiting the widespread adoption of glycomics technologies. Consequently, these financial barriers present significant challenges for innovation and growth in this field.

Market Trends of the Global Glycobiology Market

The Global Glycobiology market is experiencing significant growth, fueled by the rising interest in personalized medicine that emphasizes tailored treatment approaches. This evolving landscape highlights the crucial role of glycomics in developing targeted therapies based on unique glycan profiles, which can enhance drug efficacy for specific diseases. As healthcare systems increasingly adopt individualized treatment protocols, the demand for glycoscience innovations is set to expand. Additionally, advancements in glycan analysis techniques and their applications in drug development and diagnostics further bolster market expansion, positioning glycomics as an essential component in the future of therapeutics and precision medicine.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Glycobiology Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Enzymes
  • Glycosidases
  • Neuraminidases
  • Glycosyltransferases
  • Sialyltransferases
  • Others
• Instruments
  • Mass Spectrometers
  • HPLC
  • MALDI-TOF
  • Array Systems
• Carbohydrates
  • Monosaccharides
  • Oligosaccharides
  • Polysaccharides
  • Other Carbohydrates
• Kits
  • Glycan Labeling Kits
  • Glycan Purification Kits
  • Glycan Release Kits
• Reagents

Global Glycobiology Market Size by Application & CAGR (2026-2033)

• Market Overview
• Diagnostics
• Drug Discovery
• Oncology
• Immunology
• Other Applications

Global Glycobiology Market Size by End User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical Companies
• Biotechnology Companies
• Contract Research Organizations
• Other End Users

Global Glycobiology Market Size & CAGR (2026-2033)

• North America (Product Type, Application, End User)
  • US
  • Canada
• Europe (Product Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Waters Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shimadzu Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AMS Bio
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ludger Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Z Biotech, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chemily Glycoscience
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CD BioGlyco
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlycoDiag
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kode Biotech Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Glyxera GmBH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sialix Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations